Lif Service AB (Lif) board has agreed with Johan Färnstrand to go their separate ways and that he will end his role as CEO.
The fact that Lif’s board and Johan have now agreed that Johan will leave his position as CEO is due to different views on the continued governance and management of Lif, they state.
Lif’s head of analysis Karolina Antonov will step in as acting CEO as of March 18.
Photo of Johan Färnstrand
Karolinska Development has announced that CEO Torbjörn Bjerke leaves the company. Bjerke will be replaced by Klaus Wilgenbus until a new permanent CEO has been appointed. Torbjörn Bjerke leaves his position as CEO on September 30, 2014, and Klaus Wilgenbus steps down from his Board position in Karolinska Development and assumes his new duties with…
Frida Lawenius, who has been Deputy Director General of SwedenBIO since January 2020, brings experience from both political influence and strategic development into her new role. ”Frida Lawenius is an experienced leader who is well driven in the life science industry’s needs and in the daily operations of SwedenBIO’s office.…
Gedea Biotech has announced that Anna-Karin Areskog has been appointed QA Director. “I am passionate about contributing to small innovative companies like Gedea with my experience. Realizing the large unmet need for Gedea’s product pHyph for relieving symptoms and preventing recurrence of bacterial vaginosis, I am so proud to be…
Nanoform Finland will convene an extraordinary general meeting (EGM) on November 17 to elect Jeanne Thoma as a new board member. “Following the successful completion of our clinical trial and commercial expansion, we’ve reached an exciting point in Nanoform’s growth trajectory and are delighted to welcome Ms. Thoma as a…
